Journal of Clinical Nursing·YesterdayPatient Perspectives on a Nurse-Led Personalised Cardiovascular Risk Intervention in Type 2 Diabetes: A Qualitative Study Within the VOLTAIRE TrialTrial in peopleInterventionsPaper
JACC Asia·7 OctElevated Lipoprotein(a) in Asian Populations and its Implications for Cardiovascular DiseaseSystematic review of observational studiesLipoproteinPaper
Heart, Lung & Circulation·4 OctMarked Variability in Lipid Profile Reporting Among Australian Pathology Providers: A National Cross-Sectional Review of Low-Density Lipoprotein CholesterolCross-sectional study of 17 peopleIndustry & policyPaper
JACC Advances·18 SepSex Differences in Coronary Atheroma Regression After Intensive Lipid-Lowering Therapy: A Pooled AnalysisTrial in peopleInterventionsPaper
Bone·16 SepA conceptual model of a pathway from osteoporosis to atherosclerosis: A scoping reviewSystematic reviewBones and jointsPaper
Journal of Clinical Lipidology·11 SepA ≥20% increase in circulating Lp(a) after the commencement of statins, and subsequent risks of atherosclerotic cardiovascular diseases in patients with coronary artery diseaseCohort study of 100 peopleStatinsPaper
Journal of the American College of Cardiology·31 AugEffect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)Randomised trial in 213 peopleInterventionsPaper
The New England Journal of Medicine·31 AugAtorvastatin, Cardiovascular Events, and Disability-free Survival in Older AdultsRandomised trial in 9,971 peopleAtorvastatinPaper
Journal of the American Heart Association·31 AugLipidic Plaque Features of Polyvascular Disease in Response to Low-Density Lipoprotein Cholesterol <55 mg/dL: Implication of Circulating Lipoprotein(a) LevelsStudy in peoplePopulationsPaper
The Lancet Regional Health Western Pacific·27 AugThe impact and evolution of environmental/occupational, behavioural, and metabolic risk factors on CVD burdens in the Asia-Pacific region from 1990 to 2023: a secondary analysis of the Global Burden of Disease Study 2023Computational studyCardiovascular diseasePaper
Nature Health·26 AugFeasibility and outcomes of the DNA Screen nationwide adult genomic screening pilotTrial in 10,263 peopleInterventionsPaper
JACC Advances·19 AugEffect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery: Post-Hoc Analysis of Newton-CABG CardioLink-5Trial in peopleInterventionsPaper
Circulation·18 AugEffect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary AnalysisRandomised trial in 17,604 peopleSemaglutidePaper
Circulation·18 AugBempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes TrialRandomised trial in 13,970 peopleBempedoic acidPaper
Diabetes, Obesity & Metabolism·17 AugRetatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 DiabetesRandomised trial in peopleRetatrutidePaper
European Heart Journal Imaging Methods and Practice·8 AugCharacterization of intraplaque haemorrhage in statin-treated patients with stable coronary artery disease: multi-modality imaging with non-contrast T1-weighted cardiac magnetic resonance, optical coherence tomography, and near-infrared spectroscopyStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2026 Abstract·5 JunThe SURPASS-CVOT Retinopathy Substudy: Retinal Status after Treatment with Tirzepatide or Dulaglutide in Patients with Type 2 Diabetes and Risk for Progressive RetinopathyTrial in peopleInterventionsPaper